Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
about
Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progressPAK1 is a novel cardiac protective signaling moleculeLow body temperature governs the decline of circulating lymphocytes during hibernation through sphingosine-1-phosphate.The differential effects of FTY720 on functional recovery and infarct size following myocardial ischaemia/reperfusion.Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusionCardiovascular effects of fingolimod: A review article.S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart.Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system.Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction.Novel roles of PAK1 in the heart.Functional variants of the sphingosine-1-phosphate receptor 1 gene associate with asthma susceptibilityImplication of sphingosin-1-phosphate in cardiovascular regulation.Myocardial AKT: the omnipresent nexus.Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling.Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery.HDL and cholesterol: life after the divorce?Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.Lysophospholipid receptor activation of RhoA and lipid signaling pathways.Cardiac GPCR-Mediated EGFR Transactivation: Impact and Therapeutic Implications.The p21-activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration.Sphingosine 1-phosphate elicits RhoA-dependent proliferation and MRTF-A mediated gene induction in CPCs.Activation of sphingosine 1-phosphate receptor-1 by SEW2871 improves cognitive function in Alzheimer's disease model ratsSphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System.Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy.Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis--insights into possible drug mechanism.An engineered S1P chaperone attenuates hypertension and ischemic injury.Phytosphingosine-1-phosphate represses the hydrogen peroxide-induced activation of c-Jun N-terminal kinase in human dermal fibroblasts through the phosphatidylinositol 3-kinase/Akt pathway.Preconditioning potential of purmorphamine: a hedgehog activator against ischaemic reperfusion injury in ovariectomised rat heart.Apelin-induced cardioprotection against ischaemia/reperfusion injury: roles of epidermal growth factor and Src.Immunomodulation by splenectomy or by FTY720 protects the heart against ischemia reperfusion injury.Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore.
P2860
Q27001065-AFFE270E-A13F-4F83-94C9-E0248B46A4EDQ28251952-AA5B22F1-2D38-437B-8D5F-8798E9AF609FQ30498088-E3BBD676-FF21-4497-AF9A-69394070CA4DQ33613072-F7D51DDA-8FC0-48DA-8903-B29331910C87Q34113032-1C1CC30E-7EE1-4C2C-891E-9AE4287FD39AQ34558943-311D9EF4-E48B-46C2-B652-ACE3F6A9CE19Q34979795-B5C612DB-2EA3-41DF-8B1A-DEDF5625A33CQ35130512-BD1431D5-0A07-47CE-B511-A790F2EE4457Q35395763-CD522C54-0A9B-4A65-A22A-4A8F7CBF98E0Q36072077-D07DB441-5B49-485F-938B-1043E4E33FF4Q36376815-DAB369D4-D216-41C6-BE1A-28E456F86163Q36390340-4A10A2F1-D239-4400-9888-A4122D07E74DQ36898368-9824B4AA-E455-4434-9193-4ED3DCFC6EE3Q36908289-6EB6E653-A99D-4E05-8476-FE9F6E83EE8EQ37220195-CC438C16-9940-4E4D-9390-4EB5EC83C499Q37551932-AF04EDD8-586F-4195-8EC5-D474AFEA90A0Q37590250-BC07E9AB-F483-41C4-9619-59BEE13BB9ABQ37950457-EF79C529-D735-42D3-8B3D-42B1A7AD4889Q38044174-0892DD33-4438-4936-ABF0-B38F36FE3041Q38774086-B05F72D1-E69C-4C22-AA52-814FA86BF66CQ39345870-D8DD153A-32A2-4176-95F6-DD290C35046EQ39838646-A7A00ECE-482A-49CE-B14F-67C934454D5CQ40488333-C690D782-DF6F-44BC-B3B1-A5122F388E3AQ41531207-B19CD43F-68C0-4B58-B807-B19927D96FF9Q41547434-766910A6-5D29-4820-95A2-3A6420310B42Q44662050-5C746033-95A4-4813-AE48-1367F98A390AQ45423411-114FCD9F-F1EE-4C3B-AF20-441A0D7A232EQ45951802-2FE702B0-DC7D-4D60-A88A-C121F721B80CQ47600094-D1DE63F6-3397-4161-A647-471CF403008DQ48022708-C103EB5A-1873-4267-B707-721C2955C8F8Q53404505-6A6BB46A-1139-463C-B96F-18E0519C51D7Q55036362-D6EB4B6F-AF73-41B2-9B9C-9963C477D398
P2860
Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Protective effects of sphingos ...... cardial ischaemia-reperfusion.
@en
Protective effects of sphingos ...... cardial ischaemia-reperfusion.
@nl
type
label
Protective effects of sphingos ...... cardial ischaemia-reperfusion.
@en
Protective effects of sphingos ...... cardial ischaemia-reperfusion.
@nl
prefLabel
Protective effects of sphingos ...... cardial ischaemia-reperfusion.
@en
Protective effects of sphingos ...... cardial ischaemia-reperfusion.
@nl
P2093
P2860
P356
P1476
Protective effects of sphingos ...... cardial ischaemia-reperfusion.
@en
P2093
Andreas Bonz
Annemarie Thoma
Carolin Vogt
Georg Ertl
Natalie Burkard
Oliver Ritter
Stefan Frantz
Ulrich Hofmann
P2860
P304
P356
10.1093/CVR/CVP137
P577
2009-05-05T00:00:00Z